Prescription drug · UNAPPROVED DRUG OTHER
NU-DERM System NORMAL-Oily SKIN TRANSFORMATION NDC 62032-531
hydroquinone, homosalate, octisalate, and zinc oxide · Kit · OBAGI COSMECEUTICAL LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62032-531-00 | 62032053100 | 1 KIT in 1 CARTON (62032-531-00) * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 48 g in 1 BOTTLE, PLASTIC * 85 g in 1 TUBE * 198 mL in 1 BOTTLE, PLASTIC * 198 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTICMarketed from Dec 2, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- NU-DERM System NORMAL-Oily SKIN TRANSFORMATIONSuffix: SKIN TRANSFORMATION
- Generic name (nonproprietary)
- hydroquinone, homosalate, octisalate, and zinc oxide
- Dosage form
- Kit
- Labeler
- OBAGI COSMECEUTICAL LLC
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 62032-531_045b9599-7db1-49e4-97d1-42424c592ecdSPL ID 045b9599-7db1-49e4-97d1-42424c592ecdSPL set ID 4a96c769-4914-4eb8-8530-e4afb80c8c94RxCUI 197795
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N462032053100followed by a unit qualifier and the quantityPackage 62032-0531-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.
Excerpt only. Read the full label for complete information.